Serial

• principal source of high quality cutting-edge research in all fields of Peptide Biology

• high quality papers authored by researchers from around the globe, peer reviewed by experts in a fast, fair and constructive process

• focus on high quality peptidome research, with emphasis on excellence, innovation, both in methodology and in applications;

• source of the latest news, successes and research advances from the full scope of peptidome research, including (tandem) mass spectrometry analysis, (multidimensional) chromatography and orthogonal separation techniques, pharmacology, both in vitro and in vivo bioactivity testing, as well as molecular cloning;

• international forum for the dissemination of biological peptide research data with special attention to inter-disciplinary work combining various areas of the life sciences

• transparent, comprehensive and fast but fair peer review;

• free language correction service to non-English speaking authors;

• fast-track publication;

• professional promotion of each published paper, ensuring efficient dissemination of the data

Peptidomics is the very first journal devoted to the peptidome, i.e., the low molecular mass window of the proteome, which is still largely missed by proteomics studies. This subset of the proteome, representing essential gene products in all organisms from the most primitive to the most evolved, carries important biological information and deserves much more attention than it has received before. Peptidomics technologies involve the most modern mass spectrometry systems, as well as continuously evolving dedicated bioinformatics and molecular cloning. Together with optimized analytical methods, including (multidimensional) chromatography and orthogonal separations, the modern-day ‘life scientist’ disposes of an ever expanding peptide analytical toolbox to study virtually every biological process from an innovative research angle.

Peptidomics, therefore, publishes research results of general biological and biomedical interest, in diverse applications from academia, as well as from the biotech and pharma industry.

Peptidomics is peer-reviewed and published is English. Submissions from non-English speaking authors are provided with free language correction service from native English scientists. Peptidomics is published in electronic-only version.

• Journal Editor: Peter Verhaert, Delft University of Technology, Holand

• Editors

Journal Editor

Peter Verhaert

pverhaert@versita.com

Editorial Office

Versita Ltd.

ul. Solipska 14a/1

02-482 Warsaw, Poland

Phone: +48 22 701 50 15